Takeda Puts Up $247M For Brazilian Drugmaker Multilab
Japan-based global pharmaceutical and research company Takeda Pharmaceutical Co. Ltd. has agreed to acquire Brazilian drugmaker Multilab Industria e Comercio de Produtos Farmaceuticos Ltda. for roughly $247 million, Takeda said Friday....To view the full article, register now.
Already a subscriber? Click here to view full article